BRPI0806966A2 - Combinação de um antagonista de receptor muscarínico e um agonista beta-2-adrenoceptor - Google Patents

Combinação de um antagonista de receptor muscarínico e um agonista beta-2-adrenoceptor

Info

Publication number
BRPI0806966A2
BRPI0806966A2 BRPI0806966-2A2A BRPI0806966A BRPI0806966A2 BR PI0806966 A2 BRPI0806966 A2 BR PI0806966A2 BR PI0806966 A BRPI0806966 A BR PI0806966A BR PI0806966 A2 BRPI0806966 A2 BR PI0806966A2
Authority
BR
Brazil
Prior art keywords
beta
combination
receptor antagonist
adrenoceptor agonist
muscarine receptor
Prior art date
Application number
BRPI0806966-2A2A
Other languages
English (en)
Inventor
Harry Finch
Katherine Wiley
John Dixon
Original Assignee
Argenta Discovery Ltd
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37898913&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0806966(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Argenta Discovery Ltd, Astrazeneca Ab filed Critical Argenta Discovery Ltd
Publication of BRPI0806966A2 publication Critical patent/BRPI0806966A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0806966-2A2A 2007-02-07 2008-02-06 Combinação de um antagonista de receptor muscarínico e um agonista beta-2-adrenoceptor BRPI0806966A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0702385.6A GB0702385D0 (en) 2007-02-07 2007-02-07 New combination
PCT/GB2008/000404 WO2008096126A1 (en) 2007-02-07 2008-02-06 Combination of a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist

Publications (1)

Publication Number Publication Date
BRPI0806966A2 true BRPI0806966A2 (pt) 2014-04-08

Family

ID=37898913

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0806966-2A2A BRPI0806966A2 (pt) 2007-02-07 2008-02-06 Combinação de um antagonista de receptor muscarínico e um agonista beta-2-adrenoceptor

Country Status (18)

Country Link
US (1) US20110046191A1 (pt)
EP (1) EP2124941A1 (pt)
JP (1) JP5337054B2 (pt)
KR (1) KR20090114389A (pt)
CN (2) CN101636390B (pt)
AR (1) AR065202A1 (pt)
AU (1) AU2008212649B2 (pt)
BR (1) BRPI0806966A2 (pt)
CA (1) CA2675718A1 (pt)
CL (1) CL2008000380A1 (pt)
GB (1) GB0702385D0 (pt)
MX (1) MX2009008363A (pt)
PE (1) PE20081751A1 (pt)
RU (1) RU2460527C2 (pt)
TW (1) TW200901986A (pt)
UA (1) UA99604C2 (pt)
WO (1) WO2008096126A1 (pt)
ZA (1) ZA200905106B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0516313D0 (en) * 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
GB0704000D0 (en) * 2007-03-01 2007-04-11 Astrazeneca Ab Salts 670
NZ589091A (en) 2008-05-13 2011-07-29 Astrazeneca Ab Quinuclidine derivatives as muscarinic m3 receptor antagonists
CN102131505A (zh) * 2008-06-20 2011-07-20 阿斯利康(瑞典)有限公司 用于调节β2-肾上腺素受体活性的包含4-羟基-2-氧代-2，3-二氢-1，3-苯并噻唑-7-基化合物的药物组合物
GB0814728D0 (en) * 2008-08-12 2008-09-17 Argenta Discovery Ltd New combination
GB0823140D0 (en) * 2008-12-18 2009-01-28 Astrazeneca Ab New combination
EP3061821B1 (en) 2009-07-22 2019-07-10 Puretech Health LLC Compositions for treatment of disorders ameliorated by muscarinic receptor activation
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
JP7432506B2 (ja) 2017-10-30 2024-02-16 武田薬品工業株式会社 脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤
IL281809B (en) 2018-09-28 2022-09-01 Karuna Therapeutics Inc Compositions and methods for the treatment of diseases improved by the activation of muscarinic receptors
CN109896934A (zh) * 2019-03-08 2019-06-18 山东省药学科学院 一种高纯度2-苄氧基溴乙烷的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307141B1 (en) * 1987-09-10 1993-01-13 MERCK SHARP & DOHME LTD. Oxazoles and thiazoles for the treatment of senile dementia
FR2675142B1 (fr) * 1991-04-10 1993-06-25 Roussel Uclaf Nouveaux derives de l'acide alpha-methylene 4-[(phenoxy) methyl] 5-thiazolacetique, leur procede de preparation et les intermediaires de ce procede et leur application a titre de fongicides.
GB9603755D0 (en) * 1996-02-22 1996-04-24 Pfizer Ltd Therapeutic agents
US6057340A (en) * 1998-02-03 2000-05-02 American Home Products Corporation Oxazole derivatives as serotonin-1A receptor agonists
US6242448B1 (en) * 1998-12-17 2001-06-05 American Home Products Corporation Trisubstituted-oxazole derivatives as serotonin ligands
SE9902935D0 (sv) * 1999-08-18 1999-08-18 Astra Pharma Prod Pharmaceutical compositions
US20020052312A1 (en) * 2000-05-30 2002-05-02 Reiss Theodore F. Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists
US20020179087A1 (en) * 2001-02-01 2002-12-05 Karl-Heinz Bozung Pharmaceutical compositions containing an oxitropium salt and a betamimetic
US20020189610A1 (en) * 2001-02-01 2002-12-19 Karl-Heinz Bozung Pharmaceutical compositions containing an ipratropium salt and a betamimetic
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
RU2327450C2 (ru) * 2002-08-29 2008-06-27 Сипла Лимитед Фармацевтические продукты и композиции, содержащие специфические антихолинергические средства, агонисты бета-2 и кортикостероиды
US7332175B2 (en) * 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
US20050025718A1 (en) * 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US7745621B2 (en) * 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
GB0516313D0 (en) * 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
TW200738658A (en) * 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
WO2008017827A2 (en) * 2006-08-08 2008-02-14 Argenta Discovery Limited Azole and thiazole derivatives and their uses
WO2008096093A1 (en) * 2007-02-06 2008-08-14 Argenta Discovery Ltd. Oxazole and thiazole derivatives and their uses

Also Published As

Publication number Publication date
UA99604C2 (ru) 2012-09-10
CN101636390B (zh) 2013-06-12
CN101636390A (zh) 2010-01-27
AU2008212649A1 (en) 2008-08-14
JP5337054B2 (ja) 2013-11-06
JP2010518059A (ja) 2010-05-27
CN101678005A (zh) 2010-03-24
AR065202A1 (es) 2009-05-20
MX2009008363A (es) 2009-08-20
GB0702385D0 (en) 2007-03-21
KR20090114389A (ko) 2009-11-03
EP2124941A1 (en) 2009-12-02
PE20081751A1 (es) 2008-12-27
CL2008000380A1 (es) 2008-08-18
ZA200905106B (en) 2010-05-26
CN101678005B (zh) 2012-10-31
AU2008212649B2 (en) 2011-05-19
RU2009133261A (ru) 2011-03-20
US20110046191A1 (en) 2011-02-24
CA2675718A1 (en) 2008-07-14
TW200901986A (en) 2009-01-16
RU2460527C2 (ru) 2012-09-10
WO2008096126A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
HUS2200033I1 (hu) CGRP receptor antagonisták
HUS1800027I1 (hu) Muszkarin receptor antagonista és béta-2-adrenoreceptor agonista kombinációi
LTC2379069I2 (lt) S1p receptoriaus agonisto dozavimas
ATE524460T1 (de) Pyridon-gpr119-g-protein-gekoppelte rezeptoragonisten
EP2150115A4 (en) CYCLOPROPYLPYRROLIDINOREXIN Receptor Antagonists
BRPI1014877A8 (pt) compostos diamida tendo antagonista do receptor muscarínico e atividade agonista do receptor b2 adrenérgico.
EP1981902A4 (en) ANTAGONISTS OF NOGO RECEPTORS
DK2009992T3 (da) Il-8 receptor-antagonister
EP2120575A4 (en) AGONISTS AND ANTAGONISTS OF SPHINGOSINE-1-PHOSPHATE RECEPTORS
DK2252581T3 (da) Kappa-selektiv opioidreceptorantagonist
EP2161996A4 (en) HETEROCYCLIC CARBOXAMIDE CGRP RECEPTOR ANTAGONISTS
DK2081951T3 (da) Progesteron-receptorantagonister
EP2350060A4 (en) Melanocortin receptor AGONISTS
EP2151236A4 (en) G-PROTEIN-CONJUGATED RECEPTOR AGONIST
BRPI0910118A2 (pt) antagonistas de receptores do glucagon
BRPI0919539A2 (pt) antagonistas de receptor de opioide periférico e empregos dos mesmos
EP2034832A4 (en) IL-8 RECEPTOR ANTAGONIST
BRPI0810926A2 (pt) Antagonista de crig
EP2365749A4 (en) Quinolone NEURO PEPTIDE-S-Receptor Antagonists
DK2139890T3 (da) Perifere opioidreceptor-antagonister og anvendelser deraf
DK2049478T3 (da) Substituerede N-phenylmethyl-5-oxoprolin-2-amider som P2X7-receptorantagonister og fremgangsmåder til anvendelse deraf
ATE555111T1 (de) Chinuclidinol-derivate als muscarinrezeptor- antagonisten
HRP20160950T1 (hr) Polimorfi antagonista mglur5 receptora
EP2254413A4 (en) IMIDAZOBENZAZEPIN-CGRP receptor antagonists
ATE477243T1 (de) 2-aminochinoline als 5-ht(5a)- rezeptorantagonisten

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015.